Literature DB >> 7317270

Prognostic value of preoperative serum CEA level compared to clinical staging. I. Colorectal carcinoma.

H J Staab, F A Anderer, T Brümmendorf, E Stumpf, R Fischer.   

Abstract

In a clinical investigation of observed postoperative survival, 563 patients have been registered for primary surgical treatment of colorectal cancer since 1974. The potential prognostic factors examined within the first days of hospitalization for primary resection included age of the patients, operability, location of the tumour, tumour extension and the preoperative serum CEA level. Statistical treatment of the data revealed that each of the clinical parameters except tumour location covers ranges associated with highly significant differences in survival of the patients. The preoperative serum CEA level gave prognostic information in addition to operability or tumour extension. The prognostic significance of the preoperative CEA level was still evident when selected subgroups of patients with distinct resectability and tumour extension were examined. The results indicate that the preoperative serum CEA level is an independent prognostic parameter.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7317270      PMCID: PMC2010833          DOI: 10.1038/bjc.1981.250

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.

Authors:  S Fujimoto; M I Greene; A H Sehon
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

Review 2.  Suppressor T cells in cell-mediated immunity.

Authors:  G L Asherson; M Zembala
Journal:  Br Med Bull       Date:  1976-05       Impact factor: 4.291

3.  Pre- and postoperative uses of CEA.

Authors:  J T Evans; A Mittelman; M Chu; E D Holyoke
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

4.  Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer.

Authors:  H J Staab; F A Anderer; E Stumpf; R Fischer
Journal:  Am J Surg       Date:  1978-09       Impact factor: 2.565

5.  CEA as a monitor of gastrointestinal malignancy.

Authors:  E D Holyoke; T M Chu; G P Murphy
Journal:  Cancer       Date:  1975-03       Impact factor: 6.860

6.  The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers.

Authors:  R Goslin; G Steele; J Macintyre; R Mayer; P Sugarbaker; K Cleghorn; R Wilson; N Zamcheck
Journal:  Ann Surg       Date:  1980-12       Impact factor: 12.969

7.  The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer.

Authors:  C B Wood; J G Ratcliffe; R W Burt; A J Malcolm; L H Blumgart
Journal:  Br J Surg       Date:  1980-01       Impact factor: 6.939

8.  Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum.

Authors:  M I Greene; M E Dorf; M Pierres; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

9.  Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts.

Authors:  M I Greene; S Fujimoto; A H Sehon
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

View more
  8 in total

1.  The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies.

Authors:  H J Staab; T Brümmendorf; A Hornung; F A Anderer; G Kieninger
Journal:  Klin Wochenschr       Date:  1985-02-04

2.  [The significance of the preoperative CEA value for the prognosis of rectal cancer].

Authors:  B Mentges; R Brückner; C Weiss
Journal:  Langenbecks Arch Chir       Date:  1990

3.  [The doubling time of circulating CEA as an individual prognostic criterion of recurrence in patients with gastrointestinal cancers].

Authors:  T Brümmendorf; F A Anderer; H J Staab; A Hornung; G Kieninger
Journal:  Klin Wochenschr       Date:  1986-01-15

Review 4.  The detection and evaluation of human tumor metastases.

Authors:  D J Laurence; A M Neville
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

5.  Carcinoembryonic antigen level of draining venous blood as a predictor of recurrence in colorectal cancer patient.

Authors:  Soo Young Lee; Kyung Sun Min; Jung Kee Chung; In Mok Jung; Young Joon Ahn; Ki-Tae Hwang; Hye Seong Ahn; Seung Chul Heo
Journal:  J Korean Surg Soc       Date:  2011-11-25

6.  Drug-resistant colon cancer cells produce high carcinoembryonic antigen and might not be cancer-initiating cells.

Authors:  Hsin-chung Lee; Qing-Dong Ling; Wan-Chun Yu; Chunh-Ming Hung; Ta-Chun Kao; Yi-Wei Huang; Akon Higuchi
Journal:  Drug Des Devel Ther       Date:  2013-06-17       Impact factor: 4.162

7.  Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer.

Authors:  J de Mello; L Struthers; R Turner; E H Cooper; G R Giles
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640

8.  Prognostic value of preoperative serum CEA level compared to clinical staging: II. Stomach cancer.

Authors:  H J Staab; F A Anderer; T Brümmendorf; A Hornung; R Fischer
Journal:  Br J Cancer       Date:  1982-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.